Prenatal complications and damaging environmental influences during pregnancy are known to be connected to the risk for a variety of neuropsychiatric diseases such as schizophrenia, autism, and attention deficit hyperactivity disorder. However, uniform mechanisms of direct fetotoxic influences could not be shown so far. Recently, maternal preeclampsia has been found to be a risk factor for schizophrenia in the offspring. As preeclampsia is primarily a placental disease, this finding may serve as a starting point to consider discrete placental dysfunction in general as an important contribution to the etiopathogenesis of several neuropsychiatric diseases. Here, we briefly review the current knowledge concerning links between prenatal conditions, genetic factors, and disturbed placental development, as well as between prenatal conditions, genetic factors, and the etiopathogenesis of several neuropsychiatric diseases. Furthermore, interrelations between disturbed placental development and the etiopathogenesis of these neuropsychiatric diseases are discussed. It is shown that disturbed placental development and the etiopathogenesis of several neuropsychiatric diseases show a variety of amazing similarities and interrelations. Therefore, we hypothesize that disturbances of placental development and maturation form a crucial and overlooked link between genetic predisposition, damaging environmental influences during pregnancy and the etiopathogenesis of several neuropsychiatric diseases, ultimately due to discrete abnormalities of uteroplacental and/or fetoplacental blood flow. Prospects and limitations of testing this hypothesis in human beings and in animal models are discussed. It is suggested that confirmation of this hypothesis will establish a new basis for research on prenatal roots of several neuropsychiatric diseases, with new avenues to effective primary prevention of these diseases by therapeutic intervention already during pregnancy.

Journal Section:
Mini-Review
Keywords:
Attention deficit hyperactivity disorder, Autism, Genetics, Neurodevelopment, Schizophrenia, Trophoblast, X chromosome
This content is only available via PDF.
© 2002 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2002
You do not currently have access to this content.